Printer Friendly

NORTRAN RESOURCES LTD. ANNOUNCES EQUITY ACQUISITION

 NORTRAN RESOURCES LTD. ANNOUNCES EQUITY ACQUISITION
 VANCOUVER, British Columbia, Feb. 13 /PRNewswire/ -- The board of


directors announced that Nortran Resources Ltd. (Vancouver: NRT) has acquired a 50 percent equity interest in Rhythm Search Developments Ltd. ("RSD"), a Vancouver-based pharmaceutical research company. Nortran retains an option to obtain the remaining 50 percent after July 31, 1993.
 Dr. Michael Walker, president of RSD, and his associates have discovered a new class of chemical compounds which have been proven effective during initial experiments in controlling or preventing life-threatening heart malfunctions called "ventricular arrhythmias." This condition occurs during or after a heart attack, or myocardial infarction ("MI"). RSD's new drugs are expected to increase survivability after a heart attack.
 There are currently no completely safe and effective drugs on the market for the treatment or prevention of ventricular arrhythmias associated with heart attack, North America's number one killer. The new drugs being developed in RSD's current program are expected to be both safer and more effective than those currently available. Based on the incidence of MI and the prescribing habits of cardiologists, a new drug which can prevent post-MI ventricular arrhythmias could have eventual North American sales of $500 million annually.
 A patent will be filed shortly on the first of the antiarrhythmic compounds which have been discovered. If this patent application is successful, these compounds will be subjected to several years of preclinical and clinical testing for safety and efficacy before becoming available for prescription. Once in commercial production net sales of the new drug will be subject to a royalty of 5 percent.
 Under the terms of the acquisition, Nortran will fund RSD's drug research program, beginning with a commitment for $500,000. The acquisition is subject to final Vancouver Stock Exchange approval.
 -0- 2/13/92
 /CONTACT: David Robinson of Nortran Resources, 604-685-7933, or (U.S. toll free), 800-665-7037/
 (NRT.) CO: Nortran Resources Ltd. ST: British Columbia IN: MTC SU:


KJ-JL -- LA005 -- 9571 02/13/92 09:03 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 13, 1992
Words:328
Previous Article:TENNANT COMPANY REPORTS LOWER SALES AND EARNINGS FOR 1991
Next Article:TUSCARORA PLASTICS ANNOUNCES INVESTMENT IN WHITE KNIGHT PACKAGING CORPORATION
Topics:


Related Articles
NORTRAN RESOURCES LTD. ANNOUNCES AGREEMENT WITH RHYTHM SEARCH DEVELOPMENTS LTD.
NORTRAN RESOURCES LTD. SIGNS INTERIM RESEARCH AGREEMENT
NORTRAN RESOURCES LTD. ANNOUNCES ACQUISITION OF RHYTHM SEARCH DEVELOPMENTS
NORTRAN RESOURCES LTD. ANNOUNCES APPOINTMENT OF GORDON POLITESKI AS PRESIDENT AND DIRECTOR
NORTRAN PHARMACEUTICALS ANNOUNCES KEY APPOINTMENT TO BOARD OF DIRECTORS
PARAMOUNT RESOURCES LTD. CLOSES PROPERTY ACQUISITION
Genetronics Announces Canadian Pharmaceutical, Biotechnology Executive Joins Its Board of Directors
ROBERT RIEDER - NORTRAN PHARMACEUTICALS INC (NTRDF.OB).
NORTRAN DRUG EFFECTIVE IN ATRIAL ARRHYTHMIA MODEL.
KRYSO RESOURCES PLC - Change of Nominated Adviser.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters